Group claims accreditation can serve as a powerful tool for preventing fraud.
Pharmacists are glad that a new law is compelling the Centers for Medicare & Medicaid Services to delay the implementation of Round One of the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) program. However, the American Association for Homecare has come out in opposition to the cancellation of the accreditation deadline for DMEPOS providers in the 70 metropolitan areas throughout the United States designated for Round Two of the Medicare competitive bidding program. AAHomecare explained that accreditation helps ensure quality care for Medicare beneficiaries and can serve as a powerful tool for preventing fraud. The new law, the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA), should be no reason for pushing back accreditation deadlines, it argued.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.